Spots Global Cancer Trial Database for acinar cell adenocarcinoma of the pancreas

Every month we try and update this database with for acinar cell adenocarcinoma of the pancreas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery	NCT01537107	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... Unspecified Adu...	vismodegib sirolimus positron emissi... computed tomogr... pharmacological... laboratory biom... fludeoxyglucose...	18 Years -	Mayo Clinic
Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer	NCT02178436	Acinar Cell Ade... Duct Cell Adeno... Stage IV Pancre...	gemcitabine hyd... Selinexor Pharmacological... Laboratory Biom... Nab paclitaxel	19 Years -	Barbara Ann Karmanos Cancer Institute
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine	NCT00397787	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	sunitinib malat...	18 Years -	National Cancer Institute (NCI)
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer	NCT00058201	Pancreatic Canc...	fluorouracil gemcitabine hyd... leucovorin calc... clinical observ...	18 Years -	National Cancer Institute (NCI)
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer	NCT01666730	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	metformin hydro... oxaliplatin leucovorin calc... fluorouracil laboratory biom...	18 Years -	Case Comprehensive Cancer Center
Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride	NCT00981162	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... Unspecified Adu...	sorafenib tosyl... everolimus laboratory biom... pharmacogenomic... pharmacological...	18 Years -	Roswell Park Cancer Institute
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer	NCT01666730	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	metformin hydro... oxaliplatin leucovorin calc... fluorouracil laboratory biom...	18 Years -	Case Comprehensive Cancer Center
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer	NCT01666730	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	metformin hydro... oxaliplatin leucovorin calc... fluorouracil laboratory biom...	18 Years -	Case Comprehensive Cancer Center
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer	NCT00058201	Pancreatic Canc...	fluorouracil gemcitabine hyd... leucovorin calc... clinical observ...	18 Years -	National Cancer Institute (NCI)
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung	NCT01741597	Acinar Cell Ade... Duct Cell Adeno... Liver Metastase... Lung Metastases Recurrent Breas... Recurrent Pancr... Stage IV Breast... Stage IV Pancre...	dynamic contras... pharmacological... tumor-homing pe...	18 Years -	City of Hope Medical Center
Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer	NCT00031694	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre...	paclitaxel bryostatin 1	19 Years -	National Cancer Institute (NCI)
Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer	NCT01770132	Acinar Cell Ade... Duct Cell Adeno... Stage III Pancr...	porfimer sodium endoscopic ultr... photodynamic th... gemcitabine hyd...	18 Years - 60 Years	Indiana University
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery	NCT01739439	Acinar Cell Ade... Duct Cell Adeno... Stage IIB Pancr... Stage III Pancr...	gemcitabine hyd... hyperfractionat... intensity-modul... radiosurgery diffusion-weigh...	18 Years -	Fox Chase Cancer Center
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine	NCT00397787	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre...	sunitinib malat...	18 Years -	National Cancer Institute (NCI)
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery	NCT01234935	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem...	18 Years -	Translational Oncology Research International
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery	NCT01739439	Acinar Cell Ade... Duct Cell Adeno... Stage IIB Pancr... Stage III Pancr...	gemcitabine hyd... hyperfractionat... intensity-modul... radiosurgery diffusion-weigh...	18 Years -	Fox Chase Cancer Center
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer	NCT00416793	Acinar Cell Ade... Duct Cell Adeno... Stage IV Pancre...	bortezomib carboplatin laboratory biom...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer	NCT02047474	Acinar Cell Ade... Duct Cell Adeno... Stage I Pancrea... Stage IIA Pancr... Stage IIB Pancr...	oxaliplatin leucovorin calc... irinotecan hydr... fluorouracil therapeutic con... laboratory biom...	18 Years -	Yale University
CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	NCT01839981	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre...	6,8-bis(benzylt...	18 Years -	Wake Forest University Health Sciences
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer	NCT00058201	Pancreatic Canc...	fluorouracil gemcitabine hyd... leucovorin calc... clinical observ...	18 Years -	National Cancer Institute (NCI)
CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer	NCT01839981	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre...	6,8-bis(benzylt...	18 Years -	Wake Forest University Health Sciences
Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer	NCT02178436	Acinar Cell Ade... Duct Cell Adeno... Stage IV Pancre...	gemcitabine hyd... Selinexor Pharmacological... Laboratory Biom... Nab paclitaxel	19 Years -	Barbara Ann Karmanos Cancer Institute
Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas	NCT00085371	Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre...	triapine	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: